Back to Search
ALAN KIVITZ MD
MD
Rheumatology Physician
NPI: 1447259023IndividualAccepts Medicare
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
MD026744E(PA)
Education
ALBANY MEDICAL COLLEGE OF UNION UNIVERSITY
Class of 1982
Research & Publications (20)
Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
PMID 19167595·Clin Ther·2008
4-observational
A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis.
PMID 17570469·Semin Arthritis Rheum·2007
4-observational
HUMIRA pen: a novel autoinjection device for subcutaneous injection of the fully human monoclonal antibody adalimumab.
PMID 17359217·Expert Rev Med Devices·2007
6-review
A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
PMID 16750450·Clin Ther·2006
3-trial
Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trial.
PMID 17157117·Clin Ther·2006
3-trial
Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial.
PMID 15086644·J Am Geriatr Soc·2004
3-trial
Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis.
PMID 15153172·Aliment Pharmacol Ther·2004
3-trial
Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis.
PMID 12100776·J Fam Pract·2002
3-trial
Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study.
PMID 19248129·Arthritis Rheum·2009
4-observational
Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis.
PMID 18840641·J Clin Endocrinol Metab·2009
2-rct
Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.
PMID 18701556·Ann Rheum Dis·2009
2-rct
Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy.
PMID 18634158·J Rheumatol·2008
2-rct
Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.
PMID 18050385·J Rheumatol·2008
4-observational
Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.
PMID 18668535·Arthritis Rheum·2008
2-rct
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis.
PMID 17967833·Ann Rheum Dis·2008
4-observational
Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: a Phase I, open-label, dose-escalation clinical study.
PMID 19014836·Clin Ther·2008
3-trial
Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.
PMID 17304653·J Rheumatol·2007
3-trial
Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy.
PMID 17444593·J Rheumatol·2007
3-trial
A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases.
PMID 17470434·Rheumatology (Oxford)·2007
2-rct
Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.
PMID 16463435·J Rheumatol·2006
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 175 MEADOWBROOK LN
DUNCANSVILLE, PA 16635 - Phone
- (814) 693-0300
Quick Facts
- NPI
- 1447259023
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 44
- Publications
- 20
Are you this provider?
Claim Your Profile